Advanced BioMedical Technologies, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Advanced BioMedical Technologies, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $5.62 million as of 2015-01-31, per its 10-Q filed 2015-03-23.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-03-23
- 2015-01-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.62M.
- 2014-10-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.40M.
- 2014-07-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.17M.
- 2014-04-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $4.96M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2015-01-31 | $5.62M 10-Q · filed 2015-03-23 | |
| 2014-10-31 | $5.40M 10-Q · filed 2015-03-23 | |
| 2014-07-31 | $5.17M 10-Q · filed 2014-09-22 | |
| 2014-04-30 | $4.96M 10-Q · filed 2014-06-23 | |
| 2014-01-31 | $4.77M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $4.57M 10-Q · filed 2014-09-22 | |
| 2013-07-31 | $4.15M 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $4.00M 10-Q · filed 2013-06-14 | |
| 2013-01-31 | $3.86M 10-Q · filed 2013-03-25 | |
| 2012-10-31 | $3.68M 10-Q · filed 2013-09-16 | |
| 2012-07-31 | -$3.47M 10-Q · filed 2012-09-19 | |
| 2012-04-30 | -$3.28M 10-Q · filed 2012-06-19 | |
| 2011-10-31 | $2.92M 10-K · filed 2013-02-13 | -$2.92M 10-Q · filed 2012-06-19 |
| 2011-07-31 | -$2.69M 10-Q/A · filed 2011-10-18 | |
| 2010-10-31 | -$2.44M 10-Q/A · filed 2011-10-18 |